Abstract
The present invention relates to antibodies, including humanized antibodies that bind human Microfibrillar-associated protein 4 (MFAP4). The invention also relates to uses of such antibodies.
Originalsprog | Engelsk |
---|---|
IPC | A61K39/00,C07K16/18,C07K16/28 |
Patentnummer | WO2019086580 |
Journaliseringsdato | 01/11/2018 |
Land/Område | Danmark |
Prioritetsdato | 01/11/2017 |
Prioritetsnummer | EP17199552A |
Status | Udgivet - 9. maj 2019 |